Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.jad.2020.08.031 http://scihub22266oqcxt.onion/10.1016/j.jad.2020.08.031 32858315!7439825!32858315     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32858315&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       J+Affect+Disord 2020 ; 277 (?): 337-340 Nephropedia Template TP {{tp|p=32858315|t=2020. First report of manic-like symptoms in a COVID-19 patient with no previous history of a psychiatric disorder |pdf=|usr=}}{{32858315}} gab.com Text First report of manic-like symptoms in a COVID-19 patient with no previous history of a psychiatric disorder JO: J Affect Disord http://www.kidney.de/pget.php?&tw=1&pmid=32858315 #FOAvip BACKGROUND: In December 2019, the novel coronavirus (SARS-CoV-2) infection was first reported in Wuhan city, central China, which has spread rapidly. The common clinical features of patients with SARS-CoV-2 infection included fever, fatigue, and damage to the respiratory or digestive system. However, it is still unclear whether SARS-CoV-2 infection could cause damage to the central nervous system (CNS) inducing psychiatric symptoms. CASE REPORT: Herein, we present the first case of SARS-CoV-2 infection with manic-like symptoms and describe the diagnosis, clinical course, and treatment of the case, focusing on the identifications of SARS-CoV-2 in the specimen of cerebrospinal fluid (CSF). The patient developed manic-like symptoms when his vital signs recovered on illness day 17. After manic-like attack, the detection of SARS-CoV-2 specific IgG antibody in CSF was positive, while the reverse transcriptase-polymerase chain reaction (RT-PCR) on CSF for the SARS-CoV-2 was negative. The patient received Olanzapine for treatment and his mood problems concurrently improved as indicated by scores of Young Manic Rating Scale (YMRS). LIMITATION: This is a single case report only, and the RT-PCR test for SARS-CoV-2 in CSF was not performed simultaneously when SARS-CoV-2 was positive in samples of sputum and stool. CONCLUSION: This first case of COVID-19 patient with manic-like symptoms highlights the importance of evaluation of mental health status and may contribute to our understanding of potential risk of CNS impairments by SARS-CoV-2 infection. Twit Text FOAVip First report of manic-like symptoms in a COVID-19 patient with no previous history of a psychiatric disorder ????J Affect Disord http://www.kidney.de/pget.php?&tw=1&pmid=32858315 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32858315 #FOAvip English Wikipedia <ref>{{Cite pmid|32858315}}</ref> First report of manic-like symptoms in a COVID-19 patient with no previous history of a psychiatric disorder #MMPMID32858315 Lu S; Wei N; Jiang J; Wu L; Sheng J; Zhou J; Fang Q; Chen Y; Zheng S; Chen F; Liang T; Hu S J Affect Disord 2020[Dec]; 277 (?): 337-340 PMID32858315show ga BACKGROUND: In December 2019, the novel coronavirus (SARS-CoV-2) infection was first reported in Wuhan city, central China, which has spread rapidly. The common clinical features of patients with SARS-CoV-2 infection included fever, fatigue, and damage to the respiratory or digestive system. However, it is still unclear whether SARS-CoV-2 infection could cause damage to the central nervous system (CNS) inducing psychiatric symptoms. CASE REPORT: Herein, we present the first case of SARS-CoV-2 infection with manic-like symptoms and describe the diagnosis, clinical course, and treatment of the case, focusing on the identifications of SARS-CoV-2 in the specimen of cerebrospinal fluid (CSF). The patient developed manic-like symptoms when his vital signs recovered on illness day 17. After manic-like attack, the detection of SARS-CoV-2 specific IgG antibody in CSF was positive, while the reverse transcriptase-polymerase chain reaction (RT-PCR) on CSF for the SARS-CoV-2 was negative. The patient received Olanzapine for treatment and his mood problems concurrently improved as indicated by scores of Young Manic Rating Scale (YMRS). LIMITATION: This is a single case report only, and the RT-PCR test for SARS-CoV-2 in CSF was not performed simultaneously when SARS-CoV-2 was positive in samples of sputum and stool. CONCLUSION: This first case of COVID-19 patient with manic-like symptoms highlights the importance of evaluation of mental health status and may contribute to our understanding of potential risk of CNS impairments by SARS-CoV-2 infection. |Antibodies, Viral/cerebrospinal fluid[MESH] |Antipsychotic Agents/therapeutic use[MESH] |Antiviral Agents/therapeutic use[MESH] |Betacoronavirus[MESH] |Bipolar Disorder/cerebrospinal fluid/diagnosis/drug therapy/*etiology[MESH] |Brain/diagnostic imaging[MESH] |COVID-19[MESH] |COVID-19 Testing[MESH] |Chest Pain[MESH] |China[MESH] |Clinical Laboratory Techniques[MESH] |Cobicistat/therapeutic use[MESH] |Coronavirus Infections/cerebrospinal fluid/*complications/diagnosis/therapy[MESH] |Darunavir/therapeutic use[MESH] |Dyspnea[MESH] |Fever[MESH] |Glucocorticoids/therapeutic use[MESH] |Humans[MESH] |Indoles/therapeutic use[MESH] |Magnetic Resonance Imaging[MESH] |Male[MESH] |Methylprednisolone/therapeutic use[MESH] |Middle Aged[MESH] |Moxifloxacin/therapeutic use[MESH] |Olanzapine/therapeutic use[MESH] |Pandemics[MESH] |Pharyngitis[MESH] |Pneumonia, Viral/cerebrospinal fluid/*complications/diagnosis/therapy[MESH] |Reverse Transcriptase Polymerase Chain Reaction[MESH]First report of manic-like symptoms in a COVID-19 patient with no prev(epmc).pdf DeepDyve Pubget Overpricing